Patient Characteristics and Engraftment in SCID Mice
Patient No. . | Age (yr)/Sex . | WCC (×109/L) . | Patient Outcome . | Survival (mo) . | Sample Injected in SCID . | Presentation . | Leukemia in SCID . |
---|---|---|---|---|---|---|---|
. | . | . | . | . | . | or Relapse . | . |
. | . | . | . | . | . | Sample Injected . | . |
T1 | 5/F | 191 | A: 2nd CR | 50 | PB, cryo | P | − |
T2 | 17/M | 65 | D:T | 3 | PB, fresh | P | + |
T3 | 17/F | 282 | A: 1st CR | 42 | PB, cryo | P | − |
T4 | 21/M | 900 | D:L | 12 | PB, cryo | P | + |
T5 | 31/M | 248 | D:L | 16 | PB, cryo | P | + |
T6 | 22/M | 54 | D:L | 1 | PB, fresh | R | + |
T7 | 22/M | 602 | A: 1st CR | 18 | PB, fresh | P | + |
T8 | 14/M | 490 | D:L | 4 | PB, cryo | P | + |
T9 | 16/M | 97 | D:T | 57 | BM, cryo | P | + |
T10 | 18/M | 224 | D:L | 18 | PB, cryo | P | + |
T11 | 5/F | 202 | D:T | 6 | PB, cryo | P | − |
T12 | 24/M | 263 | D:L | 11 | PB, cryo | P | + |
T13 | 40/M | 64 | D:T | 0.5 | PB, cryo | P | − |
T14 | 19/M | 34 | D:T | 6 | BM, cryo | P | + |
T15 | 23/M | 26 | A: 1st CR | 124 | PB, cryo | P | − |
T16 | 23/M | 595 | D:L | 6 | PB, cryo | P | + |
T17 | 8/M | 121 | A: 1st CR | 57 | PB, cryo | P | − |
T18 | 23/M | 231 | D:L | 10 | PB, cryo | P | + |
T19 | 21/M | 18 | A: 1st CR | 21 | PB, cryo | P | − |
Patient No. . | Age (yr)/Sex . | WCC (×109/L) . | Patient Outcome . | Survival (mo) . | Sample Injected in SCID . | Presentation . | Leukemia in SCID . |
---|---|---|---|---|---|---|---|
. | . | . | . | . | . | or Relapse . | . |
. | . | . | . | . | . | Sample Injected . | . |
T1 | 5/F | 191 | A: 2nd CR | 50 | PB, cryo | P | − |
T2 | 17/M | 65 | D:T | 3 | PB, fresh | P | + |
T3 | 17/F | 282 | A: 1st CR | 42 | PB, cryo | P | − |
T4 | 21/M | 900 | D:L | 12 | PB, cryo | P | + |
T5 | 31/M | 248 | D:L | 16 | PB, cryo | P | + |
T6 | 22/M | 54 | D:L | 1 | PB, fresh | R | + |
T7 | 22/M | 602 | A: 1st CR | 18 | PB, fresh | P | + |
T8 | 14/M | 490 | D:L | 4 | PB, cryo | P | + |
T9 | 16/M | 97 | D:T | 57 | BM, cryo | P | + |
T10 | 18/M | 224 | D:L | 18 | PB, cryo | P | + |
T11 | 5/F | 202 | D:T | 6 | PB, cryo | P | − |
T12 | 24/M | 263 | D:L | 11 | PB, cryo | P | + |
T13 | 40/M | 64 | D:T | 0.5 | PB, cryo | P | − |
T14 | 19/M | 34 | D:T | 6 | BM, cryo | P | + |
T15 | 23/M | 26 | A: 1st CR | 124 | PB, cryo | P | − |
T16 | 23/M | 595 | D:L | 6 | PB, cryo | P | + |
T17 | 8/M | 121 | A: 1st CR | 57 | PB, cryo | P | − |
T18 | 23/M | 231 | D:L | 10 | PB, cryo | P | + |
T19 | 21/M | 18 | A: 1st CR | 21 | PB, cryo | P | − |
Abbreviations: WCC, white blood cell count; P, presentation; R, relapse; A, alive; D, dead; T, death related to toxicity of treatment; L, death due to leukemia; cryo, cryopreserved; +, engraftment in SCID mice; −, no engraftment in SCID mice.